We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Feature

Hatch-Waxman Post-TC Heartland: What You Need To Know

Law360 (May 24, 2018, 4:37 PM EDT) -- The U.S. Supreme Court's TC Heartland decision, which limited where patent lawsuits can be filed, has led to a bump in cases over generic drugs in Delaware while raising some legal questions and strategic issues for pharmaceutical companies.

The high court in TC Heartland v. Kraft Food Brands Group did away with a rule that effectively allowed plaintiffs to sue companies anywhere they made sales, and imposed restrictions on where patent cases can be brought.

It's clear the ruling, which turns 1 year old Tuesday, has...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.